The agreement will see Esperion, via a subsidiary, purchase all outstanding stock of Corstasis for an upfront cash payment of ...

Some have worried about the valuations of artificial intelligence (AI) stocks and whether these players will live up to expectations. Investors also have questioned the state of the economy and are ...

Alnylam pens this deal with Tenaya as it looks to replicate the sales of its blockbuster ATTR-CM therapy, Amvuttra.

At a time when regional healthcare systems are rapidly expanding to meet rising patient expectations, Capitol Hospital in ...

Progress against cardiovascular disease in the United States has slowed — and in some cases reversed — over the past 15 years, despite major advances in treatment, according to a new Harvard-led ...

This week's round-up of pharma licensing deals features alliances involving Tenaya Therapeutics, Sino Bio, Antengene, and A2A ...

Smartwatches and other wearables promise real-time insight into heart health, but the growing volume of data can be confusing and sometimes misleading.

Nurses use an AI-powered tool to identify and address social determinants of health that influence patient outcomes.

Echocardiography outcomes show treated patients having reduced negative remodeling of heart volumesSUNNYVALE, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of ...

SINGAPORE, March 5 (Xinhua) -- Singapore will introduce an artificial intelligence (AI) assessment tool in early 2027 to help identify individuals at high risk for cardiovascular disease, the Ministry ...

McLaren Macomb in Mount Clemens has opened its upgraded cardiac catheterization lab after a $1.2 million renovation.

Before the onset of cardiovascular disease symptoms, people often develop dyslipidemia, or abnormal levels of lipids in the blood. Recent studies suggest that microbes in the gut play an important ...